Author:
Mai Yonglin,Guo Zhihua,Yin Weiqiang,Zhong Nanshan,Dicpinigaitis Peter V.,Chen Ruchong
Abstract
Symptoms associated with lung cancer mainly consist of cancer-associated pain, cough, fatigue, and dyspnea. However, underlying mechanisms of lung cancer symptom clusters remain unclear. There remains a paucity of effective treatment to ameliorate debilitating symptoms and improve the quality of life of lung cancer survivors. Recently, extracellular ATP and its receptors have attracted increasing attention among researchers in the field of oncology. Extracellular ATP in the tumor microenvironment is associated with tumor cell metabolism, proliferation, and metastasis by driving inflammation and neurotransmission via P2 purinergic signaling. Accordingly, ATP gated P2X receptors expressed on tumor cells, immune cells, and neurons play a vital role in modulating tumor development, invasion, progression, and related symptoms. P2 purinergic signaling is involved in the development of different lung cancer-related symptoms. In this review, we summarize recent findings to illustrate the role of P2X receptors in tumor proliferation, progression, metastasis, and lung cancer- related symptoms, providing an outline of potential anti-neoplastic activity of P2X receptor antagonists. Furthermore, compared with opioids, P2X receptor antagonists appear to be innovative therapeutic interventions for managing cancer symptom clusters with fewer side effects.
Reference130 articles.
1. Lung Cancer;Neal;BMJ,2019
2. Survivorship in non-Small Cell Lung Cancer: Challenges Faced and Steps Forward;Vijayvergia;J Natl Compr Cancer Netw,2015
3. Cancer Treatment & Survivorship Facts & Figures2018
4. Symptom Clusters and Their Effect on the Functional Status of Patients With Cancer;Dodd;Oncol Nurs Forum,2001
5. A Qualitative Exploration of a Respiratory Distress Symptom Cluster in Lung Cancer: Cough, Breathlessness and Fatigue;Molassiotis;Lung Cancer,2011
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献